Cargando…

Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”

Non-pharmaceutical interventions (NPI) for infectious diseases such as COVID-19 are particularly challenging given the complexities of what is both practical and ethical to randomize. We are often faced with the difficult decision between having weak trials or not having a trial at all. In a recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Haber, Noah A., Wieten, Sarah E., Smith, Emily R., Nunan, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572532/
https://www.ncbi.nlm.nih.gov/pubmed/34743755
http://dx.doi.org/10.1186/s13063-021-05755-y